Cytax

It is used to reduce the risk of breast cancer in women who are at high risk for the disease due to their age, personal medical history, and family medical history. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast.

Cabazitaxel is used to treat metastatic castration-resistant prostate cancer. It was first approved by the FDA on June 17, 2010.

Enzana is a medicine composition of Enzalutamide, which comes in capsules form and belongs to a class of drugs known as anti-androgens (anti-testosterone). This medicine works by blocking the effects of testosterone to slow the growth and spread of prostate cancer.

Ibrutinib 140mg is a targeted therapy. It inhibits the function of Bruton's tyrosine kinase (BTK). BTK is a key signaling molecule of the B-cell receptor signaling complex that plays an important role in the survival of malignant B cells. It blocks signals that stimulate malignant B cells to grow and divide uncontrollably. It is not a chemotherapy drug but one of what are termed "targeted therapies."